1. Home
  2. DAVE vs TWST Comparison

DAVE vs TWST Comparison

Compare DAVE & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dave Inc.

DAVE

Dave Inc.

HOLD

Current Price

$400.87

Market Cap

4.4B

Sector

Technology

ML Signal

HOLD

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$90.99

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAVE
TWST
Founded
2017
2013
Country
United States
United States
Employees
280
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
5.2B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
DAVE
TWST
Price
$400.87
$90.99
Analyst Decision
Strong Buy
Buy
Analyst Count
8
8
Target Price
$312.75
$46.88
AVG Volume (30 Days)
605.1K
2.2M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$376,572,000.00
Revenue This Year
$26.28
$18.91
Revenue Next Year
$17.38
$15.07
P/E Ratio
$17.85
N/A
Revenue Growth
N/A
20.32
52 Week Low
$152.21
$23.30
52 Week High
$409.00
$105.47

Technical Indicators

Market Signals
Indicator
DAVE
TWST
Relative Strength Index (RSI) 73.61 56.55
Support Level $231.19 $42.88
Resistance Level N/A $105.47
Average True Range (ATR) 22.85 6.98
MACD 3.22 -1.42
Stochastic Oscillator 91.78 40.43

Price Performance

Historical Comparison
DAVE
TWST

About DAVE Dave Inc.

Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: